Boron as a bridging ligand.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Holger Braunschweig.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Heterodinuclear bridged borylene complexes are synthesized via oxidative addition of the B-Br bond of bromoboryl complex precursors to an electron-rich palladium species. The synthetic protocol grants access to the first compound featuring the reactive bromoborylene ligand.
An unprecedented cyclisation reaction of alpha,omega-borylbromoalkanes is seen upon treatment with magnesium turnings, forming organocycloborates in high yield. The novel boratacyclopentanes and -hexanes have been characterised by X-ray crystallography.
The boron-bridged constrained geometry titanium complexes [Ti[eta5:eta1-(C5H4)B(NR2)NPh](NMe2)2][R = iPr (3), SiMe3(4)] and [Ti[eta5:eta1-(C9H6)B(NiPr2)NPh](NMe2)2](12) have been prepared in good yields by amine elimination reaction from [Ti(NMe2)4]. Subsequent deamination-chlorination with excess Me3SiCl yielded the corresponding dichloro-complexes (5, 6, 13). Reaction of the analogous ligand precursors (C5H5)B(NiPr2)N(H)R (R = Cy, tBu) with [Ti(NMe2)4] did not result in the expected bridged compounds, but rather in the half-sandwich complexes [Ti[(eta5-C5H4)B(NiPr2)N(H)R](NMe2)3][R = Cy (9), tBu (10)]. All compounds were fully characterised by means of multinuclear NMR spectroscopy. Thorough investigation of substituent effects was achieved by comparative X-ray diffraction studies on complexes 3, 5, 6 and 12.
Reaction of the diborane(4) B(2)(NMe(2))(2)I(2) with two equivalents of K[(eta(5)-C(5)H(5))M(CO)(3)] (M=Cr, Mo, W) yielded the dinuclear boryloxycarbyne complexes [[(eta(5)-C(5)H(5))(OC)(2)M(triple bond)CO](2)B(2)(NMe(2))(2)] (4 a, M=Mo; b, M=W; c, M=Cr), which were fully characterised in solution by multinuclear NMR methods. The Mo and W complexes 4 a, b proved to be kinetically favoured products of this reaction and underwent quantitative rearrangement in solution to afford the complexes [[(eta(5)-C(5)H(5))(OC)(2)M(triple bond)CO]B(NMe(2))B(NMe(2))[M(CO)(3)(eta(5)-C(5)H(5))]] (5 a, M=Mo; b, M=W); 5 a was characterised by X-ray crystallography in the solid state. Corresponding reactions of B(2)(NMe(2))(2)I(2) with only one equivalent of K[(eta(5)-C(5)H(5))M(CO)(3)] (M=Mo, W) initially afforded 1:1 mixtures of the boryloxycarbyne complexes 4 a, b and unconsumed B(2)(NMe(2))(2)I(2). This mixture, however, yielded finally the diborane(4)yl complexes [(eta(5)-C(5)H(5))(OC)(3)M[B(NMe(2))B(NMe(2))I]] (6 a, M=Mo; b, M=W) by [(eta(5)-C(5)H(5))(OC)(3)M] transfer and rearrangement. Density functional calculations were carried out for 4 c and 5 a, b.
The reactivity of the bridged chloroborylene complex [mu-BCl((eta(5)-C(5)H(4)Me)Mn(CO)(2))(2)] (1) toward pyridine was investigated under various conditions. In the presence of protic reagents such as H[Co(CO)(4)] or H[BF(4)], the formation of the aminoborylene complex [1-(mu-B)-4-H-(NC(5)H(5))((C(5)H(4)Me)Mn(CO)(2))(2)] (2) was observed. Compound 2 represents the product of an unprecedented formal 1,4-hydroboration of pyridine. Corresponding reactions of 1 with pyridine and Tl[PF(6)] afforded 2 in similar yields, thus providing evidence that the abstraction of the boron bound chloride initiates the observed reaction. Complex 2 was fully characterized in solution and in the crystal.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.